Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve The unaudited standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories Ltd has informed BSE that its Board of Directors will meet on Saturday, 14 February 2026 at the corporate office in Hyderabad. The main agenda is to consider and approve the unaudited standalone financial results for the quarter ended 31 December 2025, along with the auditors' limited review report. The trading window for designated persons has been closed from 1 January 2026 until 48 hours after the board meeting concludes. No financial numbers, forecasts, or other business items are disclosed in this filing.
This is a routine pre-results intimation with no direct impact on the stock. Investors should watch for the actual Q3 FY26 numbers and the limited review report once released after 14 February 2026 for any signals on revenue, profitability, or auditor observations.